Arcapta Neohaler and Morphine Extended-Release Capsules
Determining the interaction of Arcapta Neohaler and Morphine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indacaterol
Brand name: Arcapta Neohaler
Synonyms: n.a.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Arcapta Neohaler-Morphine Immediate-Release Tablets and Capsules
- Arcapta Neohaler-Morphine injection
- Arcapta Neohaler-Morphine Injection PF
- Arcapta Neohaler-Morphine Long-Acting Tablets
- Arcapta Neohaler-Morphine Oral Concentrate (20 mg/mL)
- Arcapta Neohaler-Morphine Oral Solution
- Morphine Extended-Release Capsules-Ardeparin Subcutaneous
- Morphine Extended-Release Capsules-Aredia
- Morphine Extended-Release Capsules-Arestin
- Morphine Extended-Release Capsules-Arestin eent
- Morphine Extended-Release Capsules-Arestin mucous membrane powder
- Morphine Extended-Release Capsules-Arformoterol